Economics and financing of vaccines for diarrheal diseases
作者： Sarah M Bartsch , Bruce Y Lee
DOI: 10.4161/HV.28885
关键词:
摘要: The considerable burden of infectious disease-caused diarrhea around the world has motivated continuing development a number vaccine candidates over past several decades with some reaching market. As all major public health interventions, understanding economics and financing vaccines against diarrheal diseases is essential to their implementation. This review focuses on each pathogens that commonly cause diarrhea, current economic burden, status development, existing evaluations vaccines. While literature growing, there room for more inquiry. Substantial gaps exist many pathogens, circumstances, effects. Economics studies are integral
elsevier.com
sci-hub.se 参考文章(94)
Rainer Fretz, Daniela Schmid, Sandra Jelovcan, Rosi Tschertou, Elke Krassnitzer, Michael Schirmer, Markus Hell, Franz Allerberger, An outbreak of norovirus gastroenteritis in an Austrian hospital, winter 2006-2007. Wiener Klinische Wochenschrift. ,vol. 121, pp. 137- 143 ,(2009) , 10.1007/S00508-008-1135-X
Doug Coyle, Kathryn Coyle, Julie A Bettinger, Scott A Halperin, Wendy Vaudry, David W Scheifele, Nicole Le Saux, Cost effectiveness of infant vaccination for rotavirus in Canada Canadian Journal of Infectious Diseases & Medical Microbiology. ,vol. 23, pp. 71- 77 ,(2012) , 10.1155/2012/327054
Keith Grimwood, Stephen B. Lambert, Richard J. Milne, Rotavirus infections and vaccines: burden of illness and potential impact of vaccination Pediatric Drugs. ,vol. 12, pp. 235- 256 ,(2010) , 10.2165/11537200-000000000-00000
Sarah M McGlone, Rachel R Bailey, Shanta M Zimmer, Michael J Popovich, Y Tian, P Ufberg, Robert R Muder, Bruce Y Lee, The economic burden of Clostridium difficile Clinical Microbiology and Infection. ,vol. 18, pp. 282- 289 ,(2012) , 10.1111/J.1469-0691.2011.03571.X
Bruce Y Lee, Zachary S Wettstein, Sarah M McGlone, Rachel R Bailey, Craig A Umscheid, Kenneth J Smith, Robert R Muder, Economic Value of Norovirus Outbreak Control Measures in Healthcare Settings Clinical Microbiology and Infection. ,vol. 17, pp. 640- 646 ,(2011) , 10.1111/J.1469-0691.2010.03345.X
Abdur Razzaque Sarker, Ziaul Islam, Iqbal Ansary Khan, Amit Saha, Fahima Chowdhury, Ashraful Islam Khan, Firdausi Qadri, Jahangir AM Khan, Cost of illness for cholera in a high risk urban area in Bangladesh: an analysis from household perspective BMC Infectious Diseases. ,vol. 13, pp. 518- 518 ,(2013) , 10.1186/1471-2334-13-518
Jonas Lundkvist, Robert Steffen, Bengt Jönsson, Cost–Benefit of WC/rBS Oral Cholera Vaccine for Vaccination Against ETEC-Caused Travelers’ Diarrhea Journal of Travel Medicine. ,vol. 16, pp. 28- 34 ,(2009) , 10.1111/J.1708-8305.2008.00270.X
Richard J. Milne, Keith Grimwood, Budget Impact and Cost-Effectiveness of Including a Pentavalent Rotavirus Vaccine in the New Zealand Childhood Immunization Schedule Value in Health. ,vol. 12, pp. 888- 898 ,(2009) , 10.1111/J.1524-4733.2009.00534.X
J. Danial, J.A. Cepeda, F. Cameron, K. Cloy, D. Wishart, K.E. Templeton, Epidemiology and costs associated with norovirus outbreaks in NHS Lothian, Scotland 2007–2009 Journal of Hospital Infection. ,vol. 79, pp. 354- 358 ,(2011) , 10.1016/J.JHIN.2011.06.018
David N. Fisman, Christina H. Chan, Elizabeth Lowcock, Monika Naus, Victoria Lee, Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: a model-based evaluation. Vaccine. ,vol. 30, pp. 7601- 7607 ,(2012) , 10.1016/J.VACCINE.2012.10.034